Literature DB >> 30852825

Development and Validation of Multiple Reaction Monitoring (MRM) Assays for Clinical Applications.

Georgia Kontostathi1, Manousos Makridakis1, Vasiliki Bitsika1, Nikolaos Tsolakos2, Antonia Vlahou1, Jerome Zoidakis3.   

Abstract

Selected/multiple reaction monitoring-mass spectrometry (SRM/MRM) is an analytical method that is frequently combined to the use of stable isotope-labeled standard (SIS) peptides for absolute protein quantification. The application of SRM/MRM is a relatively recent development in the proteomics field for analysis of biological samples (plasma, urine, cell/tissue lysates) targeting to a large extent biomarker validation. Although MRM generally by-passes the use of antibodies (being linked to sub-optimal assay specificity in many cases), bioanalytical validation of MRM protocols has not been robustly applied because of sensitivity issues, in contrary to antibody-based methods. In this chapter, we will discuss the points that should be addressed for MRM method development in clinical proteomics applications.

Keywords:  Bioanalytical validation; MRM; Plasma; Proteomics; Quantification

Mesh:

Substances:

Year:  2019        PMID: 30852825     DOI: 10.1007/978-1-4939-9164-8_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Alterations in blood proteins in the prodromal stage of bipolar II disorders.

Authors:  Hyunju Lee; Dohyun Han; Sang Jin Rhee; Jayoun Kim; Yunna Lee; Eun Young Kim; Dong Yeon Park; Sungwon Roh; Myungjae Baik; Hee Yeon Jung; Junhee Lee; Tae Young Lee; Minah Kim; Hyunsuk Shin; Hyeyoon Kim; Se Hyun Kim; Jun Soo Kwon; Yong Min Ahn; Kyooseob Ha
Journal:  Sci Rep       Date:  2022-02-24       Impact factor: 4.379

2.  Assay design for unambiguous identification and quantification of circulating pathogen-derived peptide biomarkers.

Authors:  Qingbo Shu; Shan Liu; Tonino Alonzi; Sylvia M LaCourse; Dhiraj Kumar Singh; Duran Bao; Dalton Wamalwa; Li Jiang; Christopher J Lyon; Grace John-Stewart; Deepak Kaushal; Delia Goletti; Tony Hu
Journal:  Theranostics       Date:  2022-03-21       Impact factor: 11.600

3.  Multiplexed MRM-based protein quantification of putative prognostic biomarkers for chronic kidney disease progression in plasma.

Authors:  Manousos Makridakis; Georgia Kontostathi; Eleni Petra; Rafael Stroggilos; Vasiliki Lygirou; Szymon Filip; Flore Duranton; Harald Mischak; Angel Argiles; Jerome Zoidakis; Antonia Vlahou
Journal:  Sci Rep       Date:  2020-03-16       Impact factor: 4.379

Review 4.  Mass spectrometry-based tear proteomics for noninvasive biomarker discovery.

Authors:  Erika Ponzini; Carlo Santambrogio; Antonella De Palma; Pierluigi Mauri; Silvia Tavazzi; Rita Grandori
Journal:  Mass Spectrom Rev       Date:  2021-03-24       Impact factor: 9.011

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.